Zhejiang East Asia Pharmaceutical Gestione
Gestione criteri di controllo 1/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Cheng Chi
Amministratore delegato
CN¥1.3m
Compenso totale
Percentuale dello stipendio del CEO | n/a |
Mandato del CEO | no data |
Proprietà del CEO | 6.9% |
Durata media del management | Nessun dato |
Durata media del Consiglio di amministrazione | Nessun dato |
Aggiornamenti recenti sulla gestione
Recent updates
Zhejiang East Asia Pharmaceutical's (SHSE:605177) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 06Zhejiang East Asia Pharmaceutical Co., Ltd.'s (SHSE:605177) Shares Lagging The Market But So Is The Business
Oct 02Zhejiang East Asia Pharmaceutical's (SHSE:605177) Solid Profits Have Weak Fundamentals
May 06Zhejiang East Asia Pharmaceutical Co., Ltd. (SHSE:605177) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Apr 23Take Care Before Diving Into The Deep End On Zhejiang East Asia Pharmaceutical Co., Ltd. (SHSE:605177)
Feb 28AMMINISTRATORE DELEGATO
Cheng Chi (40 yo)
no data
Mandato
CN¥1,304,900
Compensazione
Mr. Cheng Chi serves as Director and General Manager at Zhejiang East Asia Pharmaceutical Co., Ltd. and served as its Deputy Manager.